These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24400161)

  • 1. Identification of compound heterozygous KCNJ1 mutations (encoding ROMK) in a kindred with Bartter's syndrome and a functional analysis of their pathogenicity.
    Srivastava S; Li D; Edwards N; Hynes AM; Wood K; Al-Hamed M; Wroe AC; Reaich D; Moochhala SH; Welling PA; Sayer JA
    Physiol Rep; 2013 Nov; 1(6):e00160. PubMed ID: 24400161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of small conductance K+ channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice.
    Lu M; Wang T; Yan Q; Yang X; Dong K; Knepper MA; Wang W; Giebisch G; Shull GE; Hebert SC
    J Biol Chem; 2002 Oct; 277(40):37881-7. PubMed ID: 12130653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neonatal Bartter disease diagnosed with the detection of a mutation of the KCNJ1 gene which codifies the synthesis of the renal ROMK1 potassium channel].
    García Nieto V; Müller D; van der Vliet W; Claverie-Martín F
    Nefrologia; 2001; 21(5):448-55. PubMed ID: 11795013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet.
    Bailey MA; Cantone A; Yan Q; MacGregor GG; Leng Q; Amorim JB; Wang T; Hebert SC; Giebisch G; Malnic G
    Kidney Int; 2006 Jul; 70(1):51-9. PubMed ID: 16710355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocalcemia as the Initial Presentation of Type 2 Bartter Syndrome: A Family Report.
    London S; Levine MA; Li D; Spiegel R; Lebel A; Halevy R; Tenenbaum-Rakover Y
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1679-e1688. PubMed ID: 34751387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic approach to "Bartter's syndrome".
    Károlyi L; Koch MC; Grzeschik KH; Seyberth HW
    J Mol Med (Berl); 1998 Apr; 76(5):317-25. PubMed ID: 9587066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bartter's syndrome: clinical findings, genetic causes and therapeutic approach.
    Mrad FCC; Soares SBM; de Menezes Silva LAW; Dos Anjos Menezes PV; Simões-E-Silva AC
    World J Pediatr; 2021 Feb; 17(1):31-39. PubMed ID: 32488762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical and hereditary analysis of novel complex heterozygous
    Li XY; Jiang Y; Xu LJ; Duan L; Peng XY; Chen LM; Xia WB; Xing XP
    Zhonghua Nei Ke Za Zhi; 2017 Oct; 56(10):760-762. PubMed ID: 29036958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-Onset Bartter Syndrome Type II Due to a Homozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review.
    Elfert KA; Geller DS; Nelson-Williams C; Lifton RP; Al-Malki H; Nauman A
    Am J Case Rep; 2020 Sep; 21():e924527. PubMed ID: 32997650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel compound heterozygous KCNJ1 gene mutation presenting as late-onset Bartter syndrome: Case report.
    Li J; Hu S; Nie Y; Wang R; Tan M; Li H; Zhu S
    Medicine (Baltimore); 2019 Aug; 98(34):e16738. PubMed ID: 31441846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.
    Simon DB; Karet FE; Rodriguez-Soriano J; Hamdan JH; DiPietro A; Trachtman H; Sanjad SA; Lifton RP
    Nat Genet; 1996 Oct; 14(2):152-6. PubMed ID: 8841184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in
    Tian M; Peng H; Bi X; Wang YQ; Zhang YZ; Wu Y; Zhang BR
    Front Med (Lausanne); 2022; 9():862514. PubMed ID: 35463019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional consequences of ROMK mutants linked to antenatal Bartter's syndrome and implications for treatment.
    Schwalbe RA; Bianchi L; Accili EA; Brown AM
    Hum Mol Genet; 1998 Jun; 7(6):975-80. PubMed ID: 9580661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset Bartter syndrome type II.
    Gollasch B; Anistan YM; Canaan-Kühl S; Gollasch M
    Clin Kidney J; 2017 Oct; 10(5):594-599. PubMed ID: 28979772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bartter's syndrome mutation of ROMK1 exerts dominant negative effects on K(+) conductance.
    Kunzelmann K; Hübner M; Vollmer M; Ruf R; Hildebrandt F; Greger R; Schreiber R
    Cell Physiol Biochem; 2000; 10(3):117-24. PubMed ID: 10878442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bartter's and Gitelman's syndromes: from gene to clinic.
    Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D
    Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome.
    Jeck N; Derst C; Wischmeyer E; Ott H; Weber S; Rudin C; Seyberth HW; Daut J; Karschin A; Konrad M
    Kidney Int; 2001 May; 59(5):1803-11. PubMed ID: 11318951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated nephrocalcinosis due to compound heterozygous mutations in renal outer medullary potassium channel.
    Khandelwal P; Sabanadesan J; Sinha A; Hari P; Bagga A
    CEN Case Rep; 2020 Aug; 9(3):232-236. PubMed ID: 32185747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis.
    Garcia ML; Priest BT; Alonso-Galicia M; Zhou X; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Liu J; Swensen A; Pai LY; Xiao J; Hernandez M; Hoagland K; Owens K; Tang H; de Jesus RK; Roy S; Kaczorowski GJ; Pasternak A
    J Pharmacol Exp Ther; 2014 Jan; 348(1):153-64. PubMed ID: 24142912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outer medullary potassium channel knockout models reveal thick ascending limb function and dysfunction.
    Wang T
    Clin Exp Nephrol; 2012 Feb; 16(1):49-54. PubMed ID: 22038261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.